Andean Precious Metals (CVE:APM) Trading 2.4% Higher – Should You Buy?

Andean Precious Metals Corp. (CVE:APMGet Free Report) rose 2.4% during trading on Wednesday . The company traded as high as C$1.31 and last traded at C$1.30. Approximately 144,071 shares changed hands during trading, a decline of 27% from the average daily volume of 196,891 shares. The stock had previously closed at C$1.27.

Analysts Set New Price Targets

Separately, Desjardins upgraded Andean Precious Metals to a “moderate buy” rating in a research note on Thursday, October 31st.

View Our Latest Research Report on Andean Precious Metals

Andean Precious Metals Stock Performance

The stock has a 50 day moving average of C$1.54 and a 200-day moving average of C$1.21. The firm has a market capitalization of C$194.17 million, a P/E ratio of 3.42 and a beta of 1.22.

Insider Activity at Andean Precious Metals

In related news, insider 2176423 Ontario Ltd. bought 84,400 shares of Andean Precious Metals stock in a transaction on Tuesday, October 8th. The stock was acquired at an average price of C$1.51 per share, with a total value of C$127,359.60. In the last three months, insiders have bought 1,202,800 shares of company stock worth $1,607,032. Company insiders own 69.37% of the company’s stock.

About Andean Precious Metals

(Get Free Report)

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.

See Also

Receive News & Ratings for Andean Precious Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andean Precious Metals and related companies with MarketBeat.com's FREE daily email newsletter.